| GTO ID | GTC1520 |
| Trial ID | NCT02414269 |
| Disease | Mesothelioma | Breast Cancer | Pleural Cancer | Lung Cancer |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | iCasp9M28z T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin |
| Year | 2015 |
| Country | United States |
| Company sponsor | Memorial Sloan Kettering Cancer Center |
| Other ID(s) | 15-007 |
| Cohort 1 | |||||||||
|
|||||||||